Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
The Federal Trade Commission and seven states asked a federal judge on Tuesday to hold notorious 'Pharma bro' Martin Shkreli in contempt. The FTC and the states allege that Shkreli 'flagrantly and repeatedly violated' a 2022 court order that had…
FTC Wants Shkreli Sanctioned Over Pharma Industry Ban
The Federal Trade Commission and seven states asked a New York federal judge Tuesday to hold Martin Shkreli in contempt for violating a court order banning him from the pharmaceutical industry... To view the full article, register now. Already a…
FTC: 'Pharma bro' Shkreli violated lifetime industry ban, should be held in contempt
The Federal Trade Commission (FTC) and a coalition of seven states asked a federal court on Tuesday to punish Martin Shkreli for “flagrantly and repeatedly” violating a lifetime ban from being involved in the pharmaceutical industry.
Pharma Bro Martin Shkreli Could Be in Big Trouble Again
The Federal Trade Commission has asked a federal judge to hold Martin Shkreli, the former pharmaceutical executive better known as “Pharma Bro” in the 2010s, in contempt of court for allegedly publicly trading in pharmaceutical…
Pharma Has A Blind Spot And It Is Standing Behind The Pharmacy Counter
Harshit Jain, MD, is Founder & Global CEO of Doceree. A pharmaceutical brand will spend years and enormous sums establishing a medicine. Clinical evidence, physician education, patient support, the full apparatus of a modern launch. All of it…
Zealand Pharma Makes Deal With Generate Worth Up to $1.2 Billion
Zealand Pharma A/S is teaming up with Generate Biomedicines Inc. in a billion-dollar deal to develop new obesity treatments using artificial intelligence, expanding the race for the next generation of weight-loss drugs. The Danish biotechnology…
FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban
The Federal Trade Commission and seven state attorneys general say that Martin Shkreli hasn't complied with his lifetime ban from the pharmaceutical industry. In a 37-page court filing, the FTC and the attorneys general state that Shkreli has…
Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says
Martin Shkreli—the ex-pharmaceutical executive infamous for illegally hiking the price of a lifesaving anti-parasitic drug by more than 4,000 percent and getting a seven-year prison sentence for the fraudulent scheme he used to do it—…
FTC and seven states seek contempt ruling against Shkreli over pharma ban
The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on participating in the pharmaceutical industry, and they are asking a judge to hold him in…
FTC asks judge to find 'Pharma Bro' Martin Shkreli in contempt
Oct. 13 (UPI) -- The Federal Trade Commission and seven states petitioned a federal judge Tuesday to find Martin Shkreli in contempt of court because he allegedly violated a 2022 court order banning him from the pharmaceutical industry. A statement…
'Pharma Bro' Martin Shkreli broke lifetime ban on drug industry trades, feds say
“Pharma Bro” Martin Shkreli is blatantly violating his court-ordered lifetime ban from the pharmaceutical industry by trading stocks and boasting about his market bets on social media, the feds and local prosecutors say. The Federal…
Personalised cancer vaccines take a leap forward - can Swiss pharma catch up?
For decades, the idea of a vaccine to treat cancer promised more than it delivered. That may be changing. This summer, the first successful Phase III trial of an mRNA vaccine designed around each patient's own tumour was announcedExternal link by…
FTC, States Ask Court to Hold 'Pharma Bro' Shkreli in Contempt for Trading Drug Stocks
Federal and state regulators asked a federal judge Tuesday to hold Martin Shkreli in contempt, saying he has traded pharmaceutical stocks on YouTube for years in violation of a lifetime ban from the drug industry. The Federal Trade Commission and…
Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying
Big drugmakers lose blockbusters to biosimilars and generics all the time. The strongest income payers keep paying anyway, because the next wave of drugs is already throwing off cash. This roster of five US-listed pharma companies is built around…
Early gains fade by afternoon; Insurance, Pharma stocks pull indices lower
Equity benchmarks surrendered their opening gains and turned negative by midday on Wednesday, as selling in insurance and pharmaceutical stocks offset continued strength in information technology. At 1.05 pm, the Nifty 50 was trading at 22,615.25…
Receive a Daily briefing on Pharma Industry News
Get Started